Praxis Precision Medicines ratios data for the quarter ended Jun 2026. These financial ratios cover 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||
| EBT Margin | -5,557.83% | -4,482.59% | -5,499.57% | -40,447.77% | -13,011.60% | -11,001.12% | -22,593.71% | -3,782.11% | ||||||||||||||||||||
| EBIT Margin | -5,577.01% | -4,476.31% | -5,452.14% | -5,399.22% | -9,718.33% | -10,500.84% | -18,819.54% | -856.97% | ||||||||||||||||||||
| EBITDA Margin | -5,577.01% | -4,476.31% | -5,452.14% | -5,399.22% | -9,718.33% | -10,500.84% | -18,819.54% | -856.97% | ||||||||||||||||||||
| Operating Margin | -5,577.01% | -4,476.31% | -5,452.14% | -5,399.22% | -9,718.33% | -10,500.84% | -18,819.54% | -856.97% | ||||||||||||||||||||
| Net Margin | -5,557.83% | -4,482.59% | -5,499.57% | -40,447.77% | -13,011.60% | -11,001.12% | -22,593.71% | -3,782.11% | ||||||||||||||||||||
| FCF Margin | -4,809.08% | -3,996.67% | -4,971.15% | -4,633.20% | -4,839.21% | -7,640.90% | -9,105.96% | -752.00% | ||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 338.96M | 308.58M | 266.13M | 209.96M | 158.66M | 126.02M | 106.76M | 115.94M | 120.11M | 97.34M | 169.18M | 345.74M | 428.66M | 449.68M | 480.92M | 465.78M | 424.61M | 667.15M | 1,199.05M | 1,425.15M | ||||||||
| Asset Utilization RatioAsset Util. | 0.01 | 0.01 | 0.02 | 0.03 | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 | |||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -0.83 | -0.68 | -4.91 | -80.20 | -82.63 | -0.29 | -0.00M | -514.12 | -114.94 | -0.15 | -2.95 | -21.90 | -4.44 | -0.29 | -66.90 | -48.57 | -9.05 | -0.24 | -0.23 | -0.21 | ||||||||
| Times Interest Earned | -0.83 | -0.68 | -4.91 | -80.20 | -82.63 | -0.29 | -0.00M | -514.12 | -114.94 | -0.15 | -2.95 | -21.90 | -4.44 | -0.29 | -66.90 | -48.57 | -9.05 | -0.24 | -0.23 | -0.21 | ||||||||
| Valuation | ||||||||||||||||||||||||||||
| Enterprise Value | -165.68M | -138.70M | -77.85M | -56.04M | -62.44M | -61.62M | -80.84M | -124.30M | -101.08M | -81.30M | -207.42M | -351.88M | -357.03M | -392.57M | -327.99M | -301.27M | -267.16M | -599.33M | -786.87M | -758.55M | ||||||||
| Return Ratios | ||||||||||||||||||||||||||||
| Return on SalesROS | -0.56% | -0.45% | -0.55% | -4.04% | -1.30% | -1.10% | -2.26% | -0.38% | -0.57% | -0.65% | -0.70% | |||||||||||||||||
| Return on Capital EmployedROCE | -42.77% | -61.94% | -94.50% | -135.73% | -179.05% | -234.52% | -239.76% | -173.53% | -135.52% | -154.89% | -86.56% | -40.81% | -41.44% | -48.57% | -52.79% | -65.10% | -78.85% | -53.71% | -31.10% | -27.48% | ||||||||
| Return on AssetsROA | 0.00% | -0.01% | -0.01% | -0.01% | -0.02% | -0.03% | -0.03% | -0.03% | -0.02% | -0.03% | -0.02% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% |